Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Digital Health|January 25, 2024
Personalized and longitudinal electronic informed consent in clinical trials: How to move the needle?Evelien De Sutter, Liese Barbier, Pascal Borry, et al.United European Gastroenterology Journal|December 19, 2024
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank AnalysisAn Outtier, Rosanne Janssens, Liese Barbier, et al.Pharmaceutical Medicine|November 29, 2024
Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic ReviewElif Car, Yannick Vandenplas, Teresa Barcina Lacosta, et al.ESC Heart Failure|June 10, 2024
Heart failure patients' perspectives on treatment outcomes and unmet medical needs: A qualitative preference studyAlice Vanneste, Liese Barbier, Ramses Missotten, et al.Expert Opinion on Biological Therapy|March 22, 2023
Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidanceRosanne W Meijboom, Liese Barbier, Louise C Druedahl, et al.Clinical Pharmacology and Therapeutics|October 28, 2025
A Fast Path from Innovation to Safe and Effective MedicinesPeter Arlett, Falk Ehmann, Ralf Herold, et al.Exploratory Research in Clinical and Social Pharmacy|April 28, 2022
Community pharmacists' preparedness for substituting biologics and dispensing biosimilars - Lessons learned from a multinational surveyIsabelle Arnet, Melina Verbeek, Birna Almarsdóttir Anna, et al.Frontiers in Pharmacology|September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to actionRosanne Janssens, Liese Barbier, Mireille Muller, et al.Frontiers in Pharmacology|October 3, 2022
How to balance valuable innovation with affordable access to medicines in Belgium?Steven Simoens, Khadidja Abdallah, Liese Barbier, et al.International Journal of Technology Assessment in Health Care|June 16, 2023
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working GroupMilou Amber Hogervorst, Rick Vreman, Inkatuuli Heikkinen, et al.Pageof 3